Plain-English translation of NCT06786936 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This research is exploring why people with psoriatic disease (psoriasis or psoriatic arthritis) often experience depression, and whether a medication called , , or can help with both the physical disease and depressive symptoms. These medications work by targeting a specific inflammatory pathway in the body. Researchers will use advanced brain imaging to see if treating the inflammation also changes brain patterns linked to depression.
About 30โ40% of people with psoriatic disease struggle with depression, which worsens their quality of life and makes treatment harder to stick with. Recent research suggests that the inflammation causing the skin and joint symptoms may also be affecting the brain and contributing to depression. This study aims to understand this connection so doctors can better help patients with both conditions.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will start taking one of the three medications as part of your regular medical care, prescribed by your doctor. As part of the study, you will undergo advanced brain imaging scans to show how the medication affects brain activity and connectivity related to depression. The research team will track changes in both your skin and joint symptoms and your mood over time, comparing how well the treatment works on all these fronts.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United Kingdom